Familial heterozygous hypobetalipoproteinemia and breast cancer risk: A systematic review and suggestions for further research.
Lima Pessoa E, Costa Vilella Dos Reis M, Sayuri Yamamoto T, Ribeiro Neto M, Ferraro O, Alves MJ, Guedes Coelho Lopes R.
Breast J. 2019 Jul;25(4):763-765. doi: 10.1111/tbj.13341. Epub 2019 May 20.
PMID:31111608
Familial hypobetalipoproteinemia.
Linton MF, Farese RV Jr, Young SG.
J Lipid Res. 1993 Apr;34(4):521-41.
PMID:8496659
Current Diagnosis and Management of Familial Hypobetalipoproteinemia 1.
Wakabayashi T, Takahashi M, Okazaki H, Okazaki S, Yokote K, Tada H, Ogura M, Ishigaki Y, Yamashita S, Harada-Shiba M; Committee on Primary Dyslipidemia under the Research Program on Rare and Intractable Disease of the Ministry of Health, Labour and Welfare of Japan.
Association between familial hypobetalipoproteinemia and the risk of diabetes. Is this the other side of the cholesterol-diabetes connection? A systematic review of literature.
Noto D, Arca M, Tarugi P, Cefalù AB, Barbagallo CM, Averna MR.
Acta Diabetol. 2017 Feb;54(2):111-122. doi: 10.1007/s00592-016-0931-4. Epub 2016 Nov 2.
PMID:27804036
Familial hypobetalipoproteinemia: genetics and metabolism.
Schonfeld G, Lin X, Yue P.
Cell Mol Life Sci. 2005 Jun;62(12):1372-8. doi: 10.1007/s00018-005-4473-0.
PMID:15818469
Novel APOB mutation in familial hypobetalipoproteinemia.